Skip to main content
Erschienen in: Digestive Diseases and Sciences 1/2022

15.02.2021 | Original Article

Comparative Efficacy of Various Pharmacological Interventions in the Treatment of Functional Dyspepsia: A Network Meta-Analysis

verfasst von: Liang Liang, Jia Yu, Ling Xiao, Gaohua Wang

Erschienen in: Digestive Diseases and Sciences | Ausgabe 1/2022

Einloggen, um Zugang zu erhalten

Abstract

Background and Aim

Patients with functional dyspepsia often select different pharmacological treatments. We aimed to compare and rank the efficacy of different pharmacological interventions in treating functional dyspepsia.

Methods

We searched EMBASE, PubMed, Cochrane, Web of Science and MEDLINE from the date of database inception to March 28, 2019. A random-effects model was selected to conduct traditional meta-analysis to directly examine the efficacy of different pharmacological interventions. The consistency model was selected to conduct a network meta-analysis to evaluate the relative effects and rank probability of different pharmacological interventions.

Results

We included 58 trials (15,629 participants and 21 pharmacological treatments). Network meta-analysis showed that cisapride, domperidone, itopride, and levosulpiride were better than placebo, especially in short term (< 4 weeks). And levosulpiride was significantly more effective than 15 other drugs and placebo (ORs ranging between 0.05 and 0.15). Cisapride was significantly more effective than lansoprazole (OR 0.30, 95% CrI 0.09–0.99) and tegaserod (OR 0.26, 95% CrI 0.07–0.98). The rank probability showed that levosulpiride was most likely to be rank 1 (77%), cinitapride rank 2 (17%), and cisapride rank 3 (23%).

Conclusions

Our study confirmed the effectiveness of several pharmacological treatments for ameliorating functional dyspepsia. Furthermore, levosulpiride relatively ranked the best in managing FD. Physicians should be encouraged to apply promising pharmacological interventions (e.g., levosulpiride and cisapride). However, the results should be interpreted with caution due to small study effects.
Literatur
1.
Zurück zum Zitat Guevara L. Gastroduodenal functional disorders. Revista de investigacion clinica organo del Hospital de Enfermedades de la Nutricion 1971;23:221–235PubMed Guevara L. Gastroduodenal functional disorders. Revista de investigacion clinica organo del Hospital de Enfermedades de la Nutricion 1971;23:221–235PubMed
3.
Zurück zum Zitat Aoki S, Haruma K, Kusunoki H, Hata J, Hara M, Yoshida S et al. Evaluation of gastric emptying measured with the 13C-octanoic acid breath test in patients with functional dyspepsia: comparison with ultrasonography. Scand J Gastroenterol 2002;37:662–666PubMedCrossRef Aoki S, Haruma K, Kusunoki H, Hata J, Hara M, Yoshida S et al. Evaluation of gastric emptying measured with the 13C-octanoic acid breath test in patients with functional dyspepsia: comparison with ultrasonography. Scand J Gastroenterol 2002;37:662–666PubMedCrossRef
4.
Zurück zum Zitat Talley NJ, Phillips SF. Non-ulcer dyspepsia: potential causes and pathophysiology. Ann Internal Med 1988;108:865–879CrossRef Talley NJ, Phillips SF. Non-ulcer dyspepsia: potential causes and pathophysiology. Ann Internal Med 1988;108:865–879CrossRef
6.
Zurück zum Zitat Bennett EJ, Piesse C, Palmer K, Badcock CA, Tennant CC, Kellow JE. Functional gastrointestinal disorders: psychological, social, and somatic features. Gut 1998;42:414–420PubMedPubMedCentralCrossRef Bennett EJ, Piesse C, Palmer K, Badcock CA, Tennant CC, Kellow JE. Functional gastrointestinal disorders: psychological, social, and somatic features. Gut 1998;42:414–420PubMedPubMedCentralCrossRef
7.
Zurück zum Zitat Jin M, Mo Y, Ye K, Chen M, Liu Y, He C. Efficacy of serotonin receptor agonists in the treatment of functional dyspepsia: a meta-analysis. AMS 2019;15:23–32PubMed Jin M, Mo Y, Ye K, Chen M, Liu Y, He C. Efficacy of serotonin receptor agonists in the treatment of functional dyspepsia: a meta-analysis. AMS 2019;15:23–32PubMed
8.
Zurück zum Zitat Pittayanon R, Yuan Y, Bollegala NP, Khanna R, Lacy BE, Andrews CN et al. Prokinetics for functional dyspepsia: a systematic review and meta-analysis of randomized control trials. Am J Gastroenterol 2019;114:233–243PubMedCrossRef Pittayanon R, Yuan Y, Bollegala NP, Khanna R, Lacy BE, Andrews CN et al. Prokinetics for functional dyspepsia: a systematic review and meta-analysis of randomized control trials. Am J Gastroenterol 2019;114:233–243PubMedCrossRef
9.
Zurück zum Zitat Lu Y, Chen M, Huang Z, Tang C. Antidepressants in the treatment of functional dyspepsia: a systematic review and meta-analysis. PloS One 2016;11:e0157798PubMedPubMedCentralCrossRef Lu Y, Chen M, Huang Z, Tang C. Antidepressants in the treatment of functional dyspepsia: a systematic review and meta-analysis. PloS One 2016;11:e0157798PubMedPubMedCentralCrossRef
10.
Zurück zum Zitat Du LJ, Chen BR, Kim JJ, Kim S, Shen JH, Dai N. Helicobacter pylori eradication therapy for functional dyspepsia: systematic review and meta-analysis. World J Gastroenterol 2016;22:3486–3495PubMedPubMedCentralCrossRef Du LJ, Chen BR, Kim JJ, Kim S, Shen JH, Dai N. Helicobacter pylori eradication therapy for functional dyspepsia: systematic review and meta-analysis. World J Gastroenterol 2016;22:3486–3495PubMedPubMedCentralCrossRef
11.
Zurück zum Zitat Ford AC, Luthra P, Tack J, Boeckxstaens GE, Moayyedi P, Talley NJ. Efficacy of psychotropic drugs in functional dyspepsia: systematic review and meta-analysis. Gut 2017;66:411–420PubMedCrossRef Ford AC, Luthra P, Tack J, Boeckxstaens GE, Moayyedi P, Talley NJ. Efficacy of psychotropic drugs in functional dyspepsia: systematic review and meta-analysis. Gut 2017;66:411–420PubMedCrossRef
12.
Zurück zum Zitat Wang WH, Huang JQ, Zheng GF, Xia HH, Wong WM, Liu XG et al. Effects of proton-pump inhibitors on functional dyspepsia: a meta-analysis of randomized placebo-controlled trials. Clin Gastroenterol Hepatol 2007;5:178–185PubMedCrossRef Wang WH, Huang JQ, Zheng GF, Xia HH, Wong WM, Liu XG et al. Effects of proton-pump inhibitors on functional dyspepsia: a meta-analysis of randomized placebo-controlled trials. Clin Gastroenterol Hepatol 2007;5:178–185PubMedCrossRef
13.
Zurück zum Zitat Salanti G, Higgins JP, Ades AE, Ioannidis JP. Evaluation of networks of randomized trials. Stat Methods Med Res 2008;17:279–301PubMedCrossRef Salanti G, Higgins JP, Ades AE, Ioannidis JP. Evaluation of networks of randomized trials. Stat Methods Med Res 2008;17:279–301PubMedCrossRef
15.
Zurück zum Zitat Cumpston M, Li T, Page MJ, Chandler J, Welch VA, Higgins JP et al. Updated guidance for trusted systematic reviews: a new edition of the Cochrane Handbook for Systematic Reviews of Interventions. Cochrane Database Syst Rev 2019;10:ED000142 Cumpston M, Li T, Page MJ, Chandler J, Welch VA, Higgins JP et al. Updated guidance for trusted systematic reviews: a new edition of the Cochrane Handbook for Systematic Reviews of Interventions. Cochrane Database Syst Rev 2019;10:ED000142
16.
Zurück zum Zitat Yang YJ, Bang CS, Baik GH, Park TY, Shin SP, Suk KT et al. Prokinetics for the treatment of functional dyspepsia: Bayesian network meta-analysis. BMC Gastroenterol 2017;17:83PubMedPubMedCentralCrossRef Yang YJ, Bang CS, Baik GH, Park TY, Shin SP, Suk KT et al. Prokinetics for the treatment of functional dyspepsia: Bayesian network meta-analysis. BMC Gastroenterol 2017;17:83PubMedPubMedCentralCrossRef
17.
Zurück zum Zitat Miwa H, Kusano M, Arisawa T, Oshima T, Kato M, Joh T et al. Evidence-based clinical practice guidelines for functional dyspepsia. J Gastroenterol 2015;50:125–139PubMedCrossRef Miwa H, Kusano M, Arisawa T, Oshima T, Kato M, Joh T et al. Evidence-based clinical practice guidelines for functional dyspepsia. J Gastroenterol 2015;50:125–139PubMedCrossRef
18.
Zurück zum Zitat Hsu YC, Liou JM, Yang TH, Hsu WL, Lin HJ, Wu HT et al. Proton pump inhibitor versus prokinetic therapy in patients with functional dyspepsia: is therapeutic response predicted by Rome III subgroups? J Gastroenterol 2011;46:183–190PubMedCrossRef Hsu YC, Liou JM, Yang TH, Hsu WL, Lin HJ, Wu HT et al. Proton pump inhibitor versus prokinetic therapy in patients with functional dyspepsia: is therapeutic response predicted by Rome III subgroups? J Gastroenterol 2011;46:183–190PubMedCrossRef
19.
Zurück zum Zitat Jackson JL, O’Malley PG, Tomkins G, Balden E, Santoro J, Kroenke K. Treatment of functional gastrointestinal disorders with antidepressant medications: a meta-analysis. Am J Med 2000;108:65–72PubMedCrossRef Jackson JL, O’Malley PG, Tomkins G, Balden E, Santoro J, Kroenke K. Treatment of functional gastrointestinal disorders with antidepressant medications: a meta-analysis. Am J Med 2000;108:65–72PubMedCrossRef
20.
Zurück zum Zitat Mansi C, Borro P, Giacomini M, Biagini R, Mele MR, Pandolfo N et al. Comparative effects of levosulpiride and cisapride on gastric emptying and symptoms in patients with functional dyspepsia and gastroparesis. Aliment Pharmacol Ther 2000;14:561–569PubMedCrossRef Mansi C, Borro P, Giacomini M, Biagini R, Mele MR, Pandolfo N et al. Comparative effects of levosulpiride and cisapride on gastric emptying and symptoms in patients with functional dyspepsia and gastroparesis. Aliment Pharmacol Ther 2000;14:561–569PubMedCrossRef
21.
Zurück zum Zitat Song CW, Chun HJ, Kim CD, Ryu HS, Choe JG, Hyun JH. Effects of levosulpiride in patients with functional dyspepsia accompanied by delayed gastric emptying. Korean J Intern Med 1998;13:15–21PubMedPubMedCentralCrossRef Song CW, Chun HJ, Kim CD, Ryu HS, Choe JG, Hyun JH. Effects of levosulpiride in patients with functional dyspepsia accompanied by delayed gastric emptying. Korean J Intern Med 1998;13:15–21PubMedPubMedCentralCrossRef
22.
Zurück zum Zitat al-Quorain A, Larbi EB, al-Shedoki F. A double-blind, randomized, placebo-controlled trial of cisapride in Saudi Arabs with functional dyspepsia. Scand J Gastroenterol 1995;30:531–534PubMedCrossRef al-Quorain A, Larbi EB, al-Shedoki F. A double-blind, randomized, placebo-controlled trial of cisapride in Saudi Arabs with functional dyspepsia. Scand J Gastroenterol 1995;30:531–534PubMedCrossRef
23.
Zurück zum Zitat Champion MC, MacCannell KL, Thomson AB, Tanton R, Eberhard S, Sullivan SN et al. A double-blind randomized study of cisapride in the treatment of nonulcer dyspepsia. The Canadian Cisapride Nud Study Group. Can J Gastroenterol 1997;11:127–134PubMedCrossRef Champion MC, MacCannell KL, Thomson AB, Tanton R, Eberhard S, Sullivan SN et al. A double-blind randomized study of cisapride in the treatment of nonulcer dyspepsia. The Canadian Cisapride Nud Study Group. Can J Gastroenterol 1997;11:127–134PubMedCrossRef
24.
Zurück zum Zitat Wood SF, Penney SC, Cochran KM. Cisapride in functional dyspepsia: a double-blind, placebo-controlled randomized trial in general practice patients. Scand J Gastroenterol Suppl 1993;195:5–10PubMedCrossRef Wood SF, Penney SC, Cochran KM. Cisapride in functional dyspepsia: a double-blind, placebo-controlled randomized trial in general practice patients. Scand J Gastroenterol Suppl 1993;195:5–10PubMedCrossRef
25.
Zurück zum Zitat de Groot GH, de Both PS. Cisapride in functional dyspepsia in general practice. A placebo-controlled, randomized, double-blind study. Aliment Pharmacol Ther 1997;11:193–199PubMedCrossRef de Groot GH, de Both PS. Cisapride in functional dyspepsia in general practice. A placebo-controlled, randomized, double-blind study. Aliment Pharmacol Ther 1997;11:193–199PubMedCrossRef
26.
Zurück zum Zitat De Nutte N, Van Ganse W, Witterhulghe M, Defrance P. Relief of epigastric pain in nonulcer dyspepsia: controlled trial of the promotility drug cisapride. Clin Ther 1989;11:62–68PubMed De Nutte N, Van Ganse W, Witterhulghe M, Defrance P. Relief of epigastric pain in nonulcer dyspepsia: controlled trial of the promotility drug cisapride. Clin Ther 1989;11:62–68PubMed
27.
Zurück zum Zitat Franciois IDNN. Nonulcer dyspepsia: efect of the gastrointestinal prokinetic drug cisapride. Curr Ter Res 1987;41:8 Franciois IDNN. Nonulcer dyspepsia: efect of the gastrointestinal prokinetic drug cisapride. Curr Ter Res 1987;41:8
28.
Zurück zum Zitat Hansen JM, Bytzer P, Schaffalitzky de Muckadell OB. Placebo-controlled trial of cisapride and nizatidine in unselected patients with functional dyspepsia. Am J Gastroenterol 1998;93:368–374PubMedCrossRef Hansen JM, Bytzer P, Schaffalitzky de Muckadell OB. Placebo-controlled trial of cisapride and nizatidine in unselected patients with functional dyspepsia. Am J Gastroenterol 1998;93:368–374PubMedCrossRef
29.
Zurück zum Zitat Holtmann G, Gschossmann J, Mayr P, Talley NJ. A randomized placebo-controlled trial of simethicone and cisapride for the treatment of patients with functional dyspepsia. Aliment Pharmacol Ther 2002;16:1641–1648PubMedCrossRef Holtmann G, Gschossmann J, Mayr P, Talley NJ. A randomized placebo-controlled trial of simethicone and cisapride for the treatment of patients with functional dyspepsia. Aliment Pharmacol Ther 2002;16:1641–1648PubMedCrossRef
30.
Zurück zum Zitat Kellow JE, Cowan H, Shuter B, Riley JW, Lunzer MR, Eckstein RP et al. Efficacy of cisapride therapy in functional dyspepsia. Aliment Pharmacol Ther 1995;9:153–160PubMedCrossRef Kellow JE, Cowan H, Shuter B, Riley JW, Lunzer MR, Eckstein RP et al. Efficacy of cisapride therapy in functional dyspepsia. Aliment Pharmacol Ther 1995;9:153–160PubMedCrossRef
31.
Zurück zum Zitat Rosch W. Cisapride in non-ulcer dyspepsia. Results of a placebo-controlled trial. Scand J Gastroenterol 1987;22:161–164PubMedCrossRef Rosch W. Cisapride in non-ulcer dyspepsia. Results of a placebo-controlled trial. Scand J Gastroenterol 1987;22:161–164PubMedCrossRef
32.
Zurück zum Zitat Wang B, Liang X, Jia B. A controlled multi-centre clinical trial on cisapride in treatment of functional dyspepsia. Zhonghua Nei Ke Za Zhi 1995;34:180–184PubMed Wang B, Liang X, Jia B. A controlled multi-centre clinical trial on cisapride in treatment of functional dyspepsia. Zhonghua Nei Ke Za Zhi 1995;34:180–184PubMed
33.
Zurück zum Zitat Yeoh KG, Kang JY, Tay HH, Gwee KA, Tan CC, Wee A et al. Effect of cisapride on functional dyspepsia in patients with and without histological gastritis: a double-blind placebo-controlled trial. J Gastroenterol Hepatol 1997;12:13–18PubMedCrossRef Yeoh KG, Kang JY, Tay HH, Gwee KA, Tan CC, Wee A et al. Effect of cisapride on functional dyspepsia in patients with and without histological gastritis: a double-blind placebo-controlled trial. J Gastroenterol Hepatol 1997;12:13–18PubMedCrossRef
34.
Zurück zum Zitat Jm C. Cisapride in chronic dyspepsia: results of a doubleblind, placebo-controlled trial [published erratum appears in Scand]. J Gastroenterol Suppl 1993;195:4 Jm C. Cisapride in chronic dyspepsia: results of a doubleblind, placebo-controlled trial [published erratum appears in Scand]. J Gastroenterol Suppl 1993;195:4
35.
Zurück zum Zitat Van Outryve M, De Nutte N, Van Eeghem P, Gooris JP. Efficacy of cisapride in functional dyspepsia resistant to domperidone or metoclopramide: a double-blind, placebo-controlled study. Scand J Gastroenterol Suppl 1993;195:47–52PubMedCrossRef Van Outryve M, De Nutte N, Van Eeghem P, Gooris JP. Efficacy of cisapride in functional dyspepsia resistant to domperidone or metoclopramide: a double-blind, placebo-controlled study. Scand J Gastroenterol Suppl 1993;195:47–52PubMedCrossRef
36.
Zurück zum Zitat Fumagalli I, Hammer B. Cisapride versus metoclopramide in the treatment of functional dyspepsia. A double-blind comparative trial. Scand J Gastroenterol 1994;29:33–37PubMedCrossRef Fumagalli I, Hammer B. Cisapride versus metoclopramide in the treatment of functional dyspepsia. A double-blind comparative trial. Scand J Gastroenterol 1994;29:33–37PubMedCrossRef
37.
Zurück zum Zitat Halter F, Miazza B, Brignoli R. Cisapride or cimetidine in the treatment of functional dyspepsia. Results of a double-blind, randomized. Swiss multicentre study. Scand J Gastroenterol 1994;29:618–623PubMedCrossRef Halter F, Miazza B, Brignoli R. Cisapride or cimetidine in the treatment of functional dyspepsia. Results of a double-blind, randomized. Swiss multicentre study. Scand J Gastroenterol 1994;29:618–623PubMedCrossRef
38.
Zurück zum Zitat Carvalhinhos A, Fidalgo P, Freire A, Matos L. Cisapride compared with ranitidine in the treatment of functional dyspepsia. Eur J Gastroenterol Hepatol 1995;7:411–417PubMed Carvalhinhos A, Fidalgo P, Freire A, Matos L. Cisapride compared with ranitidine in the treatment of functional dyspepsia. Eur J Gastroenterol Hepatol 1995;7:411–417PubMed
39.
Zurück zum Zitat Holtmann G, Gschossmann J, Karaus M, Fischer T, Becker B, Mayr P et al. Randomised double-blind comparison of simethicone with cisapride in functional dyspepsia. Aliment Pharmacol Ther 1999;13:1459–1465PubMedCrossRef Holtmann G, Gschossmann J, Karaus M, Fischer T, Becker B, Mayr P et al. Randomised double-blind comparison of simethicone with cisapride in functional dyspepsia. Aliment Pharmacol Ther 1999;13:1459–1465PubMedCrossRef
40.
Zurück zum Zitat Mearin F, Rodrigo L, Perez-Mota A, Balboa A, Jimenez I, Sebastian JJ et al. Levosulpiride and cisapride in the treatment of dysmotility-like functional dyspepsia: a randomized, double-masked trial. Clin Gastroenterol Hepatol 2004;2:301–308PubMedCrossRef Mearin F, Rodrigo L, Perez-Mota A, Balboa A, Jimenez I, Sebastian JJ et al. Levosulpiride and cisapride in the treatment of dysmotility-like functional dyspepsia: a randomized, double-masked trial. Clin Gastroenterol Hepatol 2004;2:301–308PubMedCrossRef
41.
Zurück zum Zitat Matsueda K, Hongo M, Tack J, Saito Y, Kato H. A placebo-controlled trial of acotiamide for meal-related symptoms of functional dyspepsia. Gut 2012;61:821–828PubMedCrossRef Matsueda K, Hongo M, Tack J, Saito Y, Kato H. A placebo-controlled trial of acotiamide for meal-related symptoms of functional dyspepsia. Gut 2012;61:821–828PubMedCrossRef
42.
Zurück zum Zitat Matsueda K, Hongo M, Tack J, Aoki H, Saito Y, Kato H. Clinical trial: dose-dependent therapeutic efficacy of acotiamide hydrochloride (Z-338) in patients with functional dyspepsia—100 mg t.i.d. is an optimal dosage. Neurogastroenterol Motil 2010;22:618-e173PubMedCrossRef Matsueda K, Hongo M, Tack J, Aoki H, Saito Y, Kato H. Clinical trial: dose-dependent therapeutic efficacy of acotiamide hydrochloride (Z-338) in patients with functional dyspepsia—100 mg t.i.d. is an optimal dosage. Neurogastroenterol Motil 2010;22:618-e173PubMedCrossRef
43.
Zurück zum Zitat Talley NJ, Tack J, Ptak T, Gupta R, Giguere M. Itopride in functional dyspepsia: results of two phase III multicentre, randomised, double-blind, placebo-controlled trials. Gut 2008;57:740–746PubMedCrossRef Talley NJ, Tack J, Ptak T, Gupta R, Giguere M. Itopride in functional dyspepsia: results of two phase III multicentre, randomised, double-blind, placebo-controlled trials. Gut 2008;57:740–746PubMedCrossRef
44.
Zurück zum Zitat Holtmann G, Talley NJ, Liebregts T, Adam B, Parow C. A placebo-controlled trial of itopride in functional dyspepsia. N Engl J Med 2006;354:832–840PubMedCrossRef Holtmann G, Talley NJ, Liebregts T, Adam B, Parow C. A placebo-controlled trial of itopride in functional dyspepsia. N Engl J Med 2006;354:832–840PubMedCrossRef
45.
Zurück zum Zitat Sun JZC, Chu Y, Yuan YZ, Li ZS, Liu XG et al. A multi-center, doubleblind, randomized and controlled trial of itopride hydrochloride in treatment of functional dyspepsia. Shanghai Yixue 2003;26:9 Sun JZC, Chu Y, Yuan YZ, Li ZS, Liu XG et al. A multi-center, doubleblind, randomized and controlled trial of itopride hydrochloride in treatment of functional dyspepsia. Shanghai Yixue 2003;26:9
46.
Zurück zum Zitat Hong LY, Li GP, Hua HX, Jie C, Hi LNZ, An TD, et al. Itopride in treatment of 104 patients with functional dyspepsia: a randomized, double-blind controlled clinical trial. Chin J New Drugs Clin Remedies 2005. Hong LY, Li GP, Hua HX, Jie C, Hi LNZ, An TD, et al. Itopride in treatment of 104 patients with functional dyspepsia: a randomized, double-blind controlled clinical trial. Chin J New Drugs Clin Remedies 2005.
47.
Zurück zum Zitat Mo JZLD, Jiang JH et al. A multi-center clinical trial of itopride hydrochloride in the treatment of functional dyspepsia. Zhongguo Xinyao Zazhi 2003;12:9 Mo JZLD, Jiang JH et al. A multi-center clinical trial of itopride hydrochloride in the treatment of functional dyspepsia. Zhongguo Xinyao Zazhi 2003;12:9
48.
Zurück zum Zitat Li-Ya Z. A multicentre clinical trial on itopride hydrochloride for treatment of functional dyspepsia. Chin J Clin Pharmacol. 2000. Li-Ya Z. A multicentre clinical trial on itopride hydrochloride for treatment of functional dyspepsia. Chin J Clin Pharmacol. 2000.
49.
Zurück zum Zitat Zhu CQMY, Zeng MD et al. A clinical study of hydrochloride itopride in the treatment of functional dyspepsia. Zhongguo Yaoke Daxue Xuebao 2005;6:3 Zhu CQMY, Zeng MD et al. A clinical study of hydrochloride itopride in the treatment of functional dyspepsia. Zhongguo Yaoke Daxue Xuebao 2005;6:3
50.
Zurück zum Zitat Amarapurkar D, Rane P. Randomised, double-blind, comparative study to evaluate the efficacy and safety of ganaton (itopride hydrochloride) and mosapride citrate in the management of functional dyspepsia. J Indian Med Assoc 2004;102:735–737PubMed Amarapurkar D, Rane P. Randomised, double-blind, comparative study to evaluate the efficacy and safety of ganaton (itopride hydrochloride) and mosapride citrate in the management of functional dyspepsia. J Indian Med Assoc 2004;102:735–737PubMed
51.
Zurück zum Zitat Hallerback BI, Bommelaer G, Bredberg E, Campbell M, Hellblom M, Lauritsen K et al. Dose finding study of mosapride in functional dyspepsia: a placebo-controlled, randomized study. Aliment Pharmacol Ther 2002;16:959–967PubMedCrossRef Hallerback BI, Bommelaer G, Bredberg E, Campbell M, Hellblom M, Lauritsen K et al. Dose finding study of mosapride in functional dyspepsia: a placebo-controlled, randomized study. Aliment Pharmacol Ther 2002;16:959–967PubMedCrossRef
52.
Zurück zum Zitat Otaka M, Jin M, Odashima M, Matsuhashi T, Wada I, Horikawa Y et al. New strategy of therapy for functional dyspepsia using famotidine, mosapride and amitriptyline. Aliment Pharmacol Ther 2005;21:42–46PubMedCrossRef Otaka M, Jin M, Odashima M, Matsuhashi T, Wada I, Horikawa Y et al. New strategy of therapy for functional dyspepsia using famotidine, mosapride and amitriptyline. Aliment Pharmacol Ther 2005;21:42–46PubMedCrossRef
53.
Zurück zum Zitat Chen SY, Wang JY, Zhu CW, Yuan YZ, Zou B, Xia L et al. A randomized controlled Multi-center clinical trial on mosapride in the treatment of functional dyspepsia. Zhonghua Liu Xing Bing Xue Za Zhi 2004;25:165–168PubMed Chen SY, Wang JY, Zhu CW, Yuan YZ, Zou B, Xia L et al. A randomized controlled Multi-center clinical trial on mosapride in the treatment of functional dyspepsia. Zhonghua Liu Xing Bing Xue Za Zhi 2004;25:165–168PubMed
54.
Zurück zum Zitat Jinkun L, Ming R, Xiaozhong P, Yinglian X, Siyun W, Li Y, et al. Short-term efficacy of mosapride dispersible tablet on postprandial distress syndrome. Chin J Gastroenterol. 2009. Jinkun L, Ming R, Xiaozhong P, Yinglian X, Siyun W, Li Y, et al. Short-term efficacy of mosapride dispersible tablet on postprandial distress syndrome. Chin J Gastroenterol. 2009.
55.
Zurück zum Zitat Kinoshita YHT, Kawamura A, Yuki M, Amano K, Sato H et al. Effects of famotidine, mosapride and tandospirone for treatment of functional dyspepsia. Aliment Pharm Ther 2005;21:4 Kinoshita YHT, Kawamura A, Yuki M, Amano K, Sato H et al. Effects of famotidine, mosapride and tandospirone for treatment of functional dyspepsia. Aliment Pharm Ther 2005;21:4
56.
Zurück zum Zitat Shnhc T. Usefulness of famotidine in functional dyspepsia patient treatment: comparison among prokinetic, acid suppression and antianxiety therapies. Aliment Pharm Ther 2005;21:6 Shnhc T. Usefulness of famotidine in functional dyspepsia patient treatment: comparison among prokinetic, acid suppression and antianxiety therapies. Aliment Pharm Ther 2005;21:6
57.
Zurück zum Zitat Vakil N, Laine L, Talley NJ, Zakko SF, Tack J, Chey WD et al. Tegaserod treatment for dysmotility-like functional dyspepsia: results of two randomized, controlled trials. Am J Gastroenterol 2008;103:1906–1919PubMed Vakil N, Laine L, Talley NJ, Zakko SF, Tack J, Chey WD et al. Tegaserod treatment for dysmotility-like functional dyspepsia: results of two randomized, controlled trials. Am J Gastroenterol 2008;103:1906–1919PubMed
58.
Zurück zum Zitat Bekhti A, Rutgeerts L. Domperidone in the treatment of functional dyspepsia in patients with delayed gastric emptying. Postgrad Med J 1979;55:30–32PubMed Bekhti A, Rutgeerts L. Domperidone in the treatment of functional dyspepsia in patients with delayed gastric emptying. Postgrad Med J 1979;55:30–32PubMed
59.
Zurück zum Zitat Van Outryve M, Lauwers W, Verbeke S. Domperidone for the symptomatic treatment of chronic post-prandial nausea and vomiting. Postgrad Med J 1979;55:33–35PubMed Van Outryve M, Lauwers W, Verbeke S. Domperidone for the symptomatic treatment of chronic post-prandial nausea and vomiting. Postgrad Med J 1979;55:33–35PubMed
60.
Zurück zum Zitat Van de Mierop L, Rutgeerts L, Van den Langenbergh B, Staessen A. Oral domperidone in chronic postprandial dyspepsia. A double-blind placebo-controlled evaluation. Digestion 1979;19:244–250PubMedCrossRef Van de Mierop L, Rutgeerts L, Van den Langenbergh B, Staessen A. Oral domperidone in chronic postprandial dyspepsia. A double-blind placebo-controlled evaluation. Digestion 1979;19:244–250PubMedCrossRef
61.
Zurück zum Zitat Davis RH, Clench MH, Mathias JR. Effects of domperidone in patients with chronic unexplained upper gastrointestinal symptoms: a double-blind, placebo-controlled study. Dig Dis Sci 1988;33:1505–1511PubMedCrossRef Davis RH, Clench MH, Mathias JR. Effects of domperidone in patients with chronic unexplained upper gastrointestinal symptoms: a double-blind, placebo-controlled study. Dig Dis Sci 1988;33:1505–1511PubMedCrossRef
62.
Zurück zum Zitat Miwa H, Osada T, Nagahara A, Ohkusa T, Hojo M, Tomita T et al. Effect of a gastro-protective agent, rebamipide, on symptom improvement in patients with functional dyspepsia: a double-blind placebo-controlled study in Japan. J Gastroenterol Hepatol 2006;21:1826–1831PubMedCrossRef Miwa H, Osada T, Nagahara A, Ohkusa T, Hojo M, Tomita T et al. Effect of a gastro-protective agent, rebamipide, on symptom improvement in patients with functional dyspepsia: a double-blind placebo-controlled study in Japan. J Gastroenterol Hepatol 2006;21:1826–1831PubMedCrossRef
63.
Zurück zum Zitat Talley NJ, Riff DS, Schwartz H, Marcuard SP. Double-blind placebo-controlled multicentre studies of rebamipide, a gastroprotective drug, in the treatment of functional dyspepsia with or without Helicobacter pylori infection. Aliment Pharmacol Ther 2001;15:1603–1611PubMedCrossRef Talley NJ, Riff DS, Schwartz H, Marcuard SP. Double-blind placebo-controlled multicentre studies of rebamipide, a gastroprotective drug, in the treatment of functional dyspepsia with or without Helicobacter pylori infection. Aliment Pharmacol Ther 2001;15:1603–1611PubMedCrossRef
64.
Zurück zum Zitat Talley NJ, Locke GR, Saito YA, Almazar AE, Bouras EP, Howden CW et al. Effect of amitriptyline and escitalopram on functional dyspepsia: a multicenter. Randomized Controlled Study. Gastroenterology 2015;149:340-349 e342PubMedCrossRef Talley NJ, Locke GR, Saito YA, Almazar AE, Bouras EP, Howden CW et al. Effect of amitriptyline and escitalopram on functional dyspepsia: a multicenter. Randomized Controlled Study. Gastroenterology 2015;149:340-349 e342PubMedCrossRef
65.
Zurück zum Zitat Kaosombatwattana U, Pongprasobchai S, Limsrivilai J, Maneerattanaporn M, Leelakusolvong S, Tanwandee T. Efficacy and safety of nortriptyline in functional dyspepsia in Asians: a randomized double-blind placebo-controlled trial. J Gastroenterol Hepatol 2018;33:411–417PubMedCrossRef Kaosombatwattana U, Pongprasobchai S, Limsrivilai J, Maneerattanaporn M, Leelakusolvong S, Tanwandee T. Efficacy and safety of nortriptyline in functional dyspepsia in Asians: a randomized double-blind placebo-controlled trial. J Gastroenterol Hepatol 2018;33:411–417PubMedCrossRef
66.
Zurück zum Zitat Tan VP, Cheung TK, Wong WM, Pang R, Wong BC. Treatment of functional dyspepsia with sertraline: a double-blind randomized placebo-controlled pilot study. World J Gastroenterol 2012;18:6127–6133PubMedPubMedCentralCrossRef Tan VP, Cheung TK, Wong WM, Pang R, Wong BC. Treatment of functional dyspepsia with sertraline: a double-blind randomized placebo-controlled pilot study. World J Gastroenterol 2012;18:6127–6133PubMedPubMedCentralCrossRef
67.
Zurück zum Zitat van Kerkhoven LA, Laheij RJ, Aparicio N, De Boer WA, Van den Hazel S, Tan AC et al. Effect of the antidepressant venlafaxine in functional dyspepsia: a randomized, double-blind, placebo-controlled trial. Clin Gastroenterol Hepatol 2008;6:746–752PubMedCrossRef van Kerkhoven LA, Laheij RJ, Aparicio N, De Boer WA, Van den Hazel S, Tan AC et al. Effect of the antidepressant venlafaxine in functional dyspepsia: a randomized, double-blind, placebo-controlled trial. Clin Gastroenterol Hepatol 2008;6:746–752PubMedCrossRef
68.
Zurück zum Zitat Blum AL, Arnold R, Stolte M, Fischer M, Koelz HR. Short course acid suppressive treatment for patients with functional dyspepsia: results depend on Helicobacter pylori status, The Frosch Study Group. Gut 2000;47:473–480PubMedPubMedCentralCrossRef Blum AL, Arnold R, Stolte M, Fischer M, Koelz HR. Short course acid suppressive treatment for patients with functional dyspepsia: results depend on Helicobacter pylori status, The Frosch Study Group. Gut 2000;47:473–480PubMedPubMedCentralCrossRef
69.
Zurück zum Zitat Bolling-Sternevald E, Lauritsen K, Aalykke C, Havelund T, Knudsen T, Unge P et al. Effect of profound acid suppression in functional dyspepsia: a double-blind, randomized, placebo-controlled trial. Scand J Gastroenterol 2002;37:1395–1402PubMedCrossRef Bolling-Sternevald E, Lauritsen K, Aalykke C, Havelund T, Knudsen T, Unge P et al. Effect of profound acid suppression in functional dyspepsia: a double-blind, randomized, placebo-controlled trial. Scand J Gastroenterol 2002;37:1395–1402PubMedCrossRef
70.
Zurück zum Zitat Talley NJ, Meineche-Schmidt V, Pare P, Duckworth M, Raisanen P, Pap A et al. Efficacy of omeprazole in functional dyspepsia: double-blind, randomized, placebo-controlled trials (the Bond and Opera studies). Aliment Pharmacol Ther 1998;12:1055–1065PubMedCrossRef Talley NJ, Meineche-Schmidt V, Pare P, Duckworth M, Raisanen P, Pap A et al. Efficacy of omeprazole in functional dyspepsia: double-blind, randomized, placebo-controlled trials (the Bond and Opera studies). Aliment Pharmacol Ther 1998;12:1055–1065PubMedCrossRef
71.
Zurück zum Zitat Peura DA, Kovacs TO, Metz DC, Siepman N, Pilmer BL, Talley NJ. Lansoprazole in the treatment of functional dyspepsia: two double-blind, randomized, placebo-controlled trials. Am J Med 2004;116:740–748PubMedCrossRef Peura DA, Kovacs TO, Metz DC, Siepman N, Pilmer BL, Talley NJ. Lansoprazole in the treatment of functional dyspepsia: two double-blind, randomized, placebo-controlled trials. Am J Med 2004;116:740–748PubMedCrossRef
72.
Zurück zum Zitat Wong WM, Wong BC, Hung WK, Yee YK, Yip AW, Szeto ML et al. Double blind, randomised, placebo controlled study of four weeks of lansoprazole for the treatment of functional dyspepsia in Chinese patients. Gut 2002;51:502–506PubMedPubMedCentralCrossRef Wong WM, Wong BC, Hung WK, Yee YK, Yip AW, Szeto ML et al. Double blind, randomised, placebo controlled study of four weeks of lansoprazole for the treatment of functional dyspepsia in Chinese patients. Gut 2002;51:502–506PubMedPubMedCentralCrossRef
73.
Zurück zum Zitat van Zanten S, Armstrong D, Chiba N, Flook N, White R, Chakraborty B et al. Esomeprazole 40 mg once a day in patients with functional dyspepsia: the randomized, placebo-controlled “ENTER” trial. Am J Gastroenterol 2006;101:2096–2106PubMedCrossRef van Zanten S, Armstrong D, Chiba N, Flook N, White R, Chakraborty B et al. Esomeprazole 40 mg once a day in patients with functional dyspepsia: the randomized, placebo-controlled “ENTER” trial. Am J Gastroenterol 2006;101:2096–2106PubMedCrossRef
74.
Zurück zum Zitat Du Y, Su T, Song X, Gao J, Zou D, Zuo C et al. Efficacy and safety of cinitapride in the treatment of mild to moderate postprandial distress syndrome-predominant functional dyspepsia. J Clin Gastroenterol 2014;48:328–335PubMedCrossRef Du Y, Su T, Song X, Gao J, Zou D, Zuo C et al. Efficacy and safety of cinitapride in the treatment of mild to moderate postprandial distress syndrome-predominant functional dyspepsia. J Clin Gastroenterol 2014;48:328–335PubMedCrossRef
75.
Zurück zum Zitat Song C, Chun H, Kim C, Ryu H, Choe J, Hyun J. Effects of levosulpiride in patients with functional dyspepsia accompanied by delayed gastric emptying. Korean J Internal Med 1998;13:15–21CrossRef Song C, Chun H, Kim C, Ryu H, Choe J, Hyun J. Effects of levosulpiride in patients with functional dyspepsia accompanied by delayed gastric emptying. Korean J Internal Med 1998;13:15–21CrossRef
Metadaten
Titel
Comparative Efficacy of Various Pharmacological Interventions in the Treatment of Functional Dyspepsia: A Network Meta-Analysis
verfasst von
Liang Liang
Jia Yu
Ling Xiao
Gaohua Wang
Publikationsdatum
15.02.2021
Verlag
Springer US
Erschienen in
Digestive Diseases and Sciences / Ausgabe 1/2022
Print ISSN: 0163-2116
Elektronische ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-021-06846-1

Weitere Artikel der Ausgabe 1/2022

Digestive Diseases and Sciences 1/2022 Zur Ausgabe

UNM CLINICAL CASE CONFERENCES

A Transient Treatable Tumor of the Pancreas

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.